Clinical features of latent inhibition in schizophrenia

Schizophrenia Research

Volumn 51, Issue 2-3, 2001, Pages 149-161

  Rascle, C ^a   Mazas, O ^a   Vaiva, G ^a   Tournant, M ^a   Raybois, O ^a   Goudemand, M ^a   Thomas, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Inter species character; Latent inhibition; Schizophrenia

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; ATTENTION; CLINICAL FEATURE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HOSPITALIZATION; HUMAN; LATENT INHIBITION; LEARNING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCHIZOPHRENIA; STIMULATION;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIC PSYCHOLOGY; TASK PERFORMANCE AND ANALYSIS;

EID: 0035451111     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00162-6     Document Type: Article

References (35)

1. Positive and negative symptoms in schizophrenia. A critical reappraisal
2. Differential performance of acute and chronic schizophrenics in a latent inhibition task
3. Latent inhibition and psychotic proneness in normal subjects
4. The current status of the dopamine hypothesis of schizophrenia
5. Haloperidol enhancement of latent inhibition: Relation to therapeutic action
6. Context, cortex, and dopamine: A connectionist approach to behavior and biology in schizophrenia
7. Analysis of covariance using the rank transformation
8. Latent inhibition and recall/recognition of irrelevant stimuli as a function of preexposure duration in high and low psychotic-prone normals
9. The latent inhibition model of schizophrenic attention disorder, Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli
10. The effect of preexposure to a nonattended stimulus on subsequent learning: Latent inhibition in adults
11. The neuropsychology of schizophrenia
12. Abolition of latent inhibition in acute, but not chronic, schizophrenics
13. Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man
14. Latent inhibition in drug naive schizophrenics: Relationship to duration of illness and dopamine D2 binding using SPET
15. A simple (or simplistic?) cognitive model for schizophrenia
16. Schizophrenia. A cognitive model and its implications for psychological intervention
17. The positive and negative syndrome scale (PANSS) for schizophrenia
18. Latent inhibition in human pavlovian differential conditioning: Effect of additional stimulation after preexposure and relation to schizotypal traits
19. An animal model of attention
20. Latent inhibition in low and high "psychotic-prone" subjects
21. Latent inhibition in humans: Data, theory and implication for schizophrenics
22. Latent inhibition and schizophrenia
23. Cocaine sensitization enhances latent inhibition of a conditioned fear response
24. The brief psychiatric rating scale
25. Automatic and control processing and attention
26. Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling: Implications for a neurodevelopmental animal model of schizophrenia
27. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: Relationship to schizophrenic attention disorder
28. Latent inhibition in schizophrenia
29. Latent inhibition and autonomic responses: A psychophysiological approach
30. Facilitation of latent inhibition by haloperidol
31. Disruption of latent inhibition by acute administration of low doses of amphetamine
32. Reduced latent inhibition in people with schizophrenia: An effect of psychosis or of its treatment